Affiliations 

  • 1 a Biology Department , Faculty of Science and Arts-Khulais, King Abdulaziz University , Khulais , Saudi Arabia
  • 2 b Pharmacognosy Division, Department of Medicinal Chemistry , Biomedical Centre, Uppsala University , Box 574, SE-751 24 Uppsala , Sweden
  • 3 c Marine Toxins Laboratory, Food Toxins and Contaminants Department , National Research Centre , Dokki, Cairo , Egypt
  • 4 d H.E.J. Research Institute of Chemistry, International Center for Chemical Sciences, University of Karachi , Karachi 75270 , Pakistan
  • 5 e Department of Experimental Hematology , Karolinska University Hospital , SE-141 86 Stockholm , Sweden
  • 6 f Centre for Natural Products and Drug Discovery (CENAR), Chemistry Department , Faculty of Science, University of Malaya , 50603 Kuala Lumpur , Malaysia
Nat Prod Res, 2016;30(6):729-34.
PMID: 26186031 DOI: 10.1080/14786419.2015.1040991

Abstract

The marine soft corals Sarcophyton trocheliophorum crude extracts possessed antimicrobial activity towards pathogenic bacterial strains, i.e. Bacillus cereus, Salmonella typhi, Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa. Bioassay-guided fractionation indicated that the antimicrobial effect was due to the presence of terpenoid bioactive derivatives. Further biological assays of the n-hexane fractions were carried out using turbidity assay, inhibition zone assay and minimum inhibitory concentration for investigating the growth-inhibition effect towards the Gram-positive and Gram-negative bacteria. The fractions were screened and the structure of the isolated compound was justified by interpretation of the spectroscopic data, mainly mass spectrometry (GC-MS). The structure was assigned as (5S)-3-[(3E,5S)-5-hydroxy-3-hepten-6-yn-1-yl]-5-methyl-2(5H)-furanone and was effective at concentrations as low as 0.20 mg/mL. The above findings, in the course of our ongoing research on marine products, may implicate that the profound anti-microbial activity of the S. trocheliophorum soft corals, inhabiting the red sea reefs, is attributed to the presence of growth-inhibiting secondary metabolites mainly terpenoids.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.